Table 3.
Cancer Type | Chemotherapy Agents | Synergistic Therapy Strategy | Synergistic Therapeutic Compound |
---|---|---|---|
Colon cancer | DOX | PTT | MoS2/Bi2S3‐PEG nanosheet[ 92 ] |
Bladder cancer | DOX | PDT | Zinc phthalocyanine (ZnPC)[ 93 ] |
Gastric cancer | PTX | PDT | Tetrandrine (Tet)[ 94 ] |
Ovarian cancer | DOX | Immunotherapy | Inducible nitric oxide synthase (iNOS) substrate[ 95 ] |
Melanoma | DOX | Immunotherapy | IL‐2 and IFN‐g[ 96 ] |
Melanoma and liver cancer | DOX | Radiotherapy | Gold nanoparticles (AuNPs)[ 97 ] |
Gemcitabine derivative (GemC16) | Radiotherapy | Gemcitabine derivative (GemC16)[ 98 ] |